Department of Radiology, University of Virginia Health System, Box 800170, Lee Street, Charlottesville, VA 22908, USA.
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1340-5. doi: 10.1007/s00270-011-0325-5. Epub 2011 Dec 15.
Our purpose was to evaluate iatrogenic renal pseudoaneurysms, endovascular treatment, and outcomes.
This retrospective study (2003-2011) reported the technical and clinical outcomes of endovascular therapy for renal pseudoaneurysms in eight patients (mean age, 46 (range 24-68) years). Renal parenchymal loss evaluation was based on digital subtraction angiography and computed tomography.
We identified eight iatrogenic renal pseudoaneurysm patients with symptoms of hematuria, pain, and hematoma after renal biopsy (n = 3), surgery (n = 3), percutaneous nephrolithotomy (n = 1), and endoscopic shock-wave lithotripsy (n = 1). In six patients, the pseudoaneurysms were small-sized (<20 mm) and peripherally located and were treated solely with coil embolization (n = 5). In one patient, coil embolization was preceded by embolization with 500-700 micron embospheres to control active bleeding. The remaining two patients had large-sized (≥50 mm), centrally located renal pseudoaneurysms treated with thrombin ± coils. Technical success with immediate bleeding cessation was achieved in all patients. There were no procedure-related deaths or complications (mean follow-up, 23.5 (range, 1-67) months).
Treatment of renal pseudoaneurysms using endovascular approach is a relatively safe and viable option regardless of location (central or peripheral) and size of the lesions with minimal renal parenchymal sacrifice.
评估医源性肾假性动脉瘤、血管内治疗及结果。
本回顾性研究(2003-2011 年)报告了 8 例肾假性动脉瘤血管内治疗的技术和临床结果(平均年龄 46 岁,范围 24-68 岁)。肾实质损失评估基于数字减影血管造影和计算机断层扫描。
我们发现 8 例医源性肾假性动脉瘤患者有血尿、疼痛和血肿症状,肾活检(n=3)、手术(n=3)、经皮肾镜取石术(n=1)和内镜冲击波碎石术(n=1)后。在 6 例患者中,假性动脉瘤为小尺寸(<20mm)和外周定位,仅用线圈栓塞治疗(n=5)。在 1 例患者中,在进行线圈栓塞之前,使用 500-700 微米的 embospheres 栓塞以控制活跃性出血。另外 2 例患者为大尺寸(≥50mm)、中央定位的肾假性动脉瘤,采用凝血酶±线圈治疗。所有患者均立即止血成功,无手术相关死亡或并发症(平均随访 23.5 个月,范围 1-67 个月)。
血管内方法治疗肾假性动脉瘤是一种相对安全且可行的选择,无论病变的位置(中央或外周)和大小如何,都可以最小化肾实质损失。